Table 2.
Variable | Considers EUS-BD as a first-line treatment, n (%) | Does not consider EUS-BD as a first-line treatment, n (%) | P |
---|---|---|---|
Age ≤55 | 10 (83.3) | 38 (86.5) | 0.77 |
Female | 3 (25.0) | 11 (11.5) | 0.19 |
Geography | |||
North Americac | 1 (8.3) | 41 (42.7) | <0.01 |
Europe | 1 (8.3) | 20 (20.8) | |
Asia | 9 (75.0) | 23 (24.0) | |
Other | 1 (8.3) | 12 (12.5) | |
Formal training in therapeutic endoscopy | 7 (58.3) | 68 (70.8) | 0.38 |
Years in practice <11 | 9 (75.0) | 52 (54.2) | 0.17 |
Academic center | 3 (25.0) | 56 (58.3) | 0.03 |
Performs ERCP | 6 (50.0) | 71 (74.0) | 0.10 |
Access to EUS-BD expertise | 3 (25.0) | 72 (75.0) | <0.01 |
Performs EUS-BD | 3 (25.0) | 51 (53.1) | 0.07 |
Formal EUS-BD training | 4 (33.3) | 27 (28.1) | 0.74 |
EUS-BD: EUS-guided biliary drainage